Express Scripts launches program to cap members' out-of-pocket insulin spending

FierceHealthcare | April 03, 2019

Express Scripts is launching a program that will cap insulin costs for eligible diabetes patients at $25 for a 30-day supply. The Express Scripts Patient Assurance Program will be open to members of non-government funded pharmacy plans whose out-of-pocket costs exceed $25, Express Scripts and Cigna announced Wednesday morning. For most eligible members, this will lead to lower costs at the pharmacy counter without increasing the cost of the plan itself, Express Scripts said.  Three drug companies are participating in the program: Eli Lilly, Novo Nordisk and Sanofi. Members in Express Scripts and Cigna coverage that use insulin averaged $41.50 for a 30-day supply in 2018, so the new program will save them an average of 40%. But the program will be applicable to high-deductible plans as well, members of which are exposed to high cost-sharing before meeting their deductibles.

Spotlight

Schedule, track, and manage every stage of maintenance, calibration, and breakdown processes from anywhere, at any time. Biomedical technicians are instantly notified of work order requests with the real-time location of assets.


Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More